Company News in the Life Science Industry

»

Reset 

ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia

WASHINGTON, Dec. 3, 2019 /PRNewswire/ -- Today, ASH published new state-of-the art guidelines on the treatment of immune thrombocytopenia (ITP), a rare blood disorder characterized by a decrease in the number of platelets, the part of the blood needed for normal clotting. The Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

Precision Optics Announces Promotion of Daniel Habhegger to CFO

GARDNER, Mass., Dec. 3, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the promotion of Daniel Habhegger to Chief Financial Officer of the Company.... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019
Related companies:  Precision Optics Corporation, Inc.

Alacrita's Rob Johnson Departs for Gene Therapy Space

LONDON, Dec. 3, 2019 /PRNewswire/ -- Alacrita, a leading life science consulting firm, with offices in the United States and the United Kingdom, announces the departure of Rob Johnson who leaves the company to take on a new role at a gene... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019
Related companies:  Alacrita Consulting Inc

Global Nanotechnology & Advanced Materials Industry 2019: Nanofibers, Energy Applications, Advanced Ceramics & Nanoceramic Powders, Nanofiltration, Nanotextiles, Photonic Crystals, Opacifiers

DUBLIN, Dec. 3, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

Willow Biosciences Announces Trading Date on the Toronto Stock Exchange

CALGARY, Dec. 3, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received final approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019
Related companies:  Willow Biosciences

Zomedica Announces Management Changes

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Zomedica Pharmaceuticals Corp.

BioXcel Therapeutics Prepares to Initiate Pivotal Phase 3 Studies with BXCL501 Following Positive End-of-Phase 2 Meeting with FDA

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  BioXcel Therapeutics, Inc.

Genkyotex Reports Progress of Setanaxib Phase 2 Investigator Initiated Trials

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Genkyotex S.A.

Axovant Announces Amendment to Credit Facility with Hercules Capital

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Axovant Gene Therapies

Oyster Point Pharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Oyster Point Pharma, Inc.

Pluristem Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Pluristem Therapeutics Inc

Caraway Therapeutics Expands Leadership Team With Appointment of Martin D. Williams, MS, MBA, as Chief Executive Officer and Cristina Csimma, PharmD, MHP, as Chair of the Board of Directors

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Caraway Therapeutics

Cara Therapeutics Announces Positive Topline Data From Phase 2 Trial of Oral KORSUVA™ in Chronic Kidney Disease Patients with Moderate-to-Severe Pruritus

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Cara Therapeutics Inc.

Baudax Bio to Present at the Piper Jaffray 31st Annual Healthcare Conference

Read more ››
By: GlobenewsWire - 03 Dec 2019

Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Dynavax Technologies Corporation

Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Tonix Pharmaceuticals Holding Corp.

RTI Surgical® Accelerates Business Transformation with Senior Leadership Appointments

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  RTI Surgical, Inc.

Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Lexicon Pharmaceuticals, Inc.

Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Myriad Genetics, Inc.

Biogen Announces Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Biogen Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies